Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cingulate Inc.CING · Entity 6983 | Director · Chief Executive Officer | July 16, 2026 | July 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cingulate Inc.
Report date July 16, 2026 · Filed July 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2036-07-16 | Direct | 197,650 |
Reported balance
After 2026-07-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 197,650 · Balance 197,650 F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. |
| Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2036-07-16 | Direct | 97,350 |
Reported balance
After 2026-07-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-16 · Grant · Acquired 97,350 · Balance 97,350 F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. F2: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027. F3: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.
F2: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027.
F3: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2026 Filed Jul 20, 2026 23:37 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 97,350 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001493152-26-033972 · ownership.xml · derivative · entry 2 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,350 Underlying: Common Stock · 97,350 shares Expires 2036-07-16 F1 · derivative.exercise_date: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. F2 · derivative.exercise_date: Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027. F3 · derivative.expiration_date: If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 23:37 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 197,650 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001493152-26-033972 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,650 Underlying: Common Stock · 197,650 shares Expires 2036-07-16 F1 · derivative.exercise_date: The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:13 UTC | Cingulate Inc. CING · Entity 6983 | Tax withholdingCommon Stock | 2,959 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-009722 · ownership.xml · nonDerivative · entry 2 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,076 F2 · security: Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above. Read SEC document |
| March 09, 2026 Filed Mar 12, 2026 00:13 UTC | Cingulate Inc. CING · Entity 6983 | GrantCommon Stock | 6,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-009722 · ownership.xml · nonDerivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,035 F1 · security: Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 5,447 | $0.10 Strike: $5.04 | $544.70 |
DisclosureSEC source: 0001493152-26-006025 · ownership.xml · derivative · entry 3 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Fountainhead Shrugged, LLC Disclosed balance after: 5,447 Underlying: Common Stock · 5,447 shares Expires not disclosed F1 · date: Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. F3 · derivative.exercise_date: The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. F3 · derivative.expiration_date: The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date. F2 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 6,809 | $5.04 | $34,317.36 |
DisclosureSEC source: 0001493152-26-006025 · ownership.xml · nonDerivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Fountainhead Shrugged, LLC Disclosed balance after: 10,175 F1 · date: Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026. F2 · ownership.nature: Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 22:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 199,500 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001641172-25-018479 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,500 Underlying: Common Stock · 199,500 shares Expires 2035-07-07 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 70,489 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001493152-25-007760 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,489 Underlying: Common Stock · 70,489 shares Expires 2035-02-18 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| January 17, 2025 Filed Jan 23, 2025 00:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 27,638 | $0.00 Strike: $4.76 | $0.00 |
DisclosureSEC source: 0001493152-25-003289 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,638 Underlying: Common Stock · 27,638 shares Expires 2035-01-17 F1 · date: The option was granted for a portion of Mr. Schaffer's 2024 bonus. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 23:59 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 217,677 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001493152-24-023771 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,677 Underlying: Common Stock · 217,677 shares Expires 2034-03-04 F1 · date: The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024. F2 · derivative.exercise_date: The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 57,323 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001493152-24-009093 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,323 Underlying: Common Stock · 57,323 shares Expires 2034-03-04 F1 · derivative.exercise_date: The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date. Read SEC document |
| February 28, 2023 Filed Mar 9, 2023 02:08 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 90,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001493152-23-007046 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:03 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 200 | $0.26 Strike: $6.00 | $52.40 |
DisclosureSEC source: 0001493152-22-035892 · ownership.xml · derivative · entry 4 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,738 Underlying: Common Stock · 200 shares Expires 2026-12-10 Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 22:03 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 10,000 | $1.02 | $10,166.00 |
DisclosureSEC source: 0001493152-22-035892 · ownership.xml · nonDerivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to 1.0199 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 22:03 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 3,642 | $0.26 Strike: $6.00 | $953.11 |
DisclosureSEC source: 0001493152-22-035892 · ownership.xml · derivative · entry 3 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,538 Underlying: Common Stock · 3,642 shares Expires 2026-12-10 F3 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2506 to $0.262 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 23:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 13,267 | $1.01 | $13,399.67 |
DisclosureSEC source: 0001493152-22-035633 · ownership.xml · nonDerivative · entry 2 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 396 | $0.26 Strike: $6.00 | $102.68 |
DisclosureSEC source: 0001493152-22-035633 · ownership.xml · derivative · entry 4 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,896 Underlying: Common Stock · 396 shares Expires 2026-12-10 F2 · price: The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2458 to $0.262 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 1,733 | $1.01 | $1,750.33 |
DisclosureSEC source: 0001493152-22-035633 · ownership.xml · nonDerivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,233 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 00:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseWarrant to Purchase Common Stock · Derivative | 50,000 | $0.31 Strike: $6.00 | $15,500.00 |
DisclosureSEC source: 0001493152-22-007044 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,500 Underlying: Common Stock · 50,000 shares Expires 2026-12-10 Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 67,500 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-22-005779 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common Stock · 67,500 shares Expires 2032-02-25 F1 · derivative.exercise_date: The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantWarrant to Purchase Common Stock · Derivative | 16,500 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001493152-21-031460 · ownership.xml · derivative · entry 3 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2026-12-10 F1 · price: Reporting Person purchased 16,500 Units in the Issuer's initial public offering at $6.00 per Unit. Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:00 UTC | Cingulate Inc. CING · Entity 6983 | PurchaseCommon Stock | 16,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-031460 · ownership.xml · nonDerivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 F1 · price: Reporting Person purchased 16,500 Units in the Issuer's initial public offering at $6.00 per Unit. Each Unit consists of one share of Common Stock and one warrant to purchase one share of Common Stock. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 23:00 UTC | Cingulate Inc. CING · Entity 6983 | GrantStock Option (right to Buy) · Derivative | 179,668 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001493152-21-030998 · ownership.xml · derivative · entry 1 Schaffer Shane J. · CIK 0001883254 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,668 Underlying: Common Stock · 179,668 shares Expires 2031-12-07 F1 · derivative.exercise_date: The option vests in four equal annual installments commencing on December 7, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.